KEVIN D. FREEMAN - 23 Dec 2025 Form 4/A - Amendment Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role: Director
Signature: Jack W. Callicutt, by power of attorney
Issuer symbol: GALT
Transactions as of: 23 Dec 2025
Net transactions value: +$19,514
Form type: 4/A - Amendment
Filing time: 23 Dec 2025, 13:21:11 UTC
Date Of Original Report: 23 Dec 2025
Previous filing: 18 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
FREEMAN KEVIN D	Director	C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS	Jack W. Callicutt, by power of attorney	23 Dec 2025	0001522478

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GALT	Common Stock	Purchase	$19,514	+5,500	+11%	$3.55	55,269	23 Dec 2025	Direct
holding	GALT	Common Stock						80,000	23 Dec 2025	By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC	F1
holding	GALT	Common Stock						18,063	23 Dec 2025	IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.